应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02251 鹰瞳科技-B
未开盘 07-22 16:08:56
12.000
-0.360
-2.91%
最高
12.540
最低
11.900
成交量
24.60万
今开
12.380
昨收
12.360
日振幅
5.18%
总市值
12.43亿
流通市值
6.41亿
总股本
1.04亿
成交额
300.93万
换手率
0.46%
流通股本
5,342万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
鹰瞳科技-B盘中异动 早盘急速跳水5.30%报12.161港元
自选股智能写手 · 07-18
鹰瞳科技-B盘中异动 早盘急速跳水5.30%报12.161港元
鹰瞳科技:万语大模型通过国家深度合成服务算法备案 打造智能健康助手助力行业发展
中国财富通 · 07-12
鹰瞳科技:万语大模型通过国家深度合成服务算法备案 打造智能健康助手助力行业发展
一脉阳光医学影像产业项目持续推进 成众多耐心资本标的
中金在线 · 07-02
一脉阳光医学影像产业项目持续推进 成众多耐心资本标的
港股异动 | 一脉阳光(02522)跌超8% 股价暂现五连阴 公司为国内医学影像领域的领军企业
智通财经 · 07-02
港股异动 | 一脉阳光(02522)跌超8% 股价暂现五连阴 公司为国内医学影像领域的领军企业
鹰瞳科技-B盘中异动 大幅下挫5.59%报13.501港元
自选股智能写手 · 07-02
鹰瞳科技-B盘中异动 大幅下挫5.59%报13.501港元
大股东Mialkos Tomasz Jakub增持鹰瞳科技-B(02251)23.5万股 每股作价约15港元
智通财经网 · 06-28
大股东Mialkos Tomasz Jakub增持鹰瞳科技-B(02251)23.5万股 每股作价约15港元
鹰瞳科技-B(02251)股价显著上升10.41%,现价港币$14.0
阿斯达克财经 · 06-28
鹰瞳科技-B(02251)股价显著上升10.41%,现价港币$14.0
港股异动 | 一脉阳光(02522)早盘急挫逾20%跌破发行价 公司为国内医学影像领域的领军企业
智通财经 · 06-28
港股异动 | 一脉阳光(02522)早盘急挫逾20%跌破发行价 公司为国内医学影像领域的领军企业
鹰瞳科技-B盘中异动 早盘股价大涨6.77%报13.540港元
自选股智能写手 · 06-28
鹰瞳科技-B盘中异动 早盘股价大涨6.77%报13.540港元
港股概念追踪 |为医生节省大量的时间 中金看好AI对医疗行业生产率提升将较大(附概念股)
智通财经 · 06-28
港股概念追踪 |为医生节省大量的时间 中金看好AI对医疗行业生产率提升将较大(附概念股)
鹰瞳科技-B(02251)下跌13.73%,报12.94元/股
金融界 · 06-27
鹰瞳科技-B(02251)下跌13.73%,报12.94元/股
鹰瞳科技-B(02251)股价下跌8.533%,现价港币$13.72
阿斯达克财经 · 06-27
鹰瞳科技-B(02251)股价下跌8.533%,现价港币$13.72
鹰瞳科技-B盘中异动 大幅下挫5.34%报14.200港元
自选股智能写手 · 06-27
鹰瞳科技-B盘中异动 大幅下挫5.34%报14.200港元
广宇集团:投资者朋友,公司持有杭州全景医学影像诊断有限公司20%的股权
证券之星 · 06-13
广宇集团:投资者朋友,公司持有杭州全景医学影像诊断有限公司20%的股权
稀缺标的港股上市,医学影像第一股迈入高增长
36氪 · 06-07
稀缺标的港股上市,医学影像第一股迈入高增长
医学影像专科医疗集团一脉阳光今日在港交所上市
腾讯自选股 · 06-07
医学影像专科医疗集团一脉阳光今日在港交所上市
新股解读|一脉阳光:上市锻造龙头增长势能 打造中国医学影像服务产业名片
智通财经 · 06-07
新股解读|一脉阳光:上市锻造龙头增长势能 打造中国医学影像服务产业名片
新股消息 | 一脉阳光(02522)今日港交所上市 为中国医学影像服务第一股
智通财经 · 06-07
新股消息 | 一脉阳光(02522)今日港交所上市 为中国医学影像服务第一股
“医学影像服务第一股”诞生,一脉阳光登陆港交所开盘涨超9%
地产k线 · 06-07
“医学影像服务第一股”诞生,一脉阳光登陆港交所开盘涨超9%
鹰瞳科技-B06月06日获主力加仓114万元 环比增加533.33%
自选股智能写手 · 06-06
鹰瞳科技-B06月06日获主力加仓114万元 环比增加533.33%
加载更多
公司概况
公司名称:
鹰瞳科技-B
所属市场:
SEHK
上市日期:
--
主营业务:
鹰瞳Airdoc成立于2015年9月,总部在北京,截至2020年1月底,公司在北京、上海、广州、香港设立了子公司及研发中心。 鹰瞳Airdoc是全球视网膜影像人工智能领域的领导者和先行者,公司基于视网膜影像人工智能识别的早期检测、辅助诊断及健康风险评估解决方案,通过视网膜影像、多模态数据分析以及人工智能深度学习算法,改善了慢性病传统的早期检测及诊断方式,在医疗机构和大健康场景中实现对慢性病的无创、精确、快速、高性价比且大规模的诊断及相关健康风险评估。 2020年8月,鹰瞳Airdoc糖尿病视网膜病变眼底图像辅助诊断软件获国家药监局批准上市,在同类产品中首个获得国家药监局第三类医疗器械证书,并由此展开在国内医院的使用,协助及减轻医生的医学诊断工作。为解决未满足的医疗健康需求,公司开发了人工智能视网膜影像相关的丰富产品管线,已广泛应用于社区诊所、体检中心、保险公司、验光中心及药房等场所,为用户提供疾病辅助诊断及健康风险评估
发行价格:
--
{"stockData":{"symbol":"02251","market":"HK","secType":"STK","nameCN":"鹰瞳科技-B","latestPrice":12,"timestamp":1721635736030,"preClose":12.36,"halted":0,"volume":246000,"delay":0,"floatShares":53417001,"shares":103568013,"eps":-1.3701959,"marketStatus":"未开盘","marketStatusCode":0,"change":-0.36,"latestTime":"07-22 16:08:56","open":12.38,"high":12.54,"low":11.9,"amount":3009308,"amplitude":0.05178,"askPrice":12.2,"askSize":1000,"bidPrice":12,"bidSize":400,"shortable":0,"etf":0,"ttmEps":-1.3701958764014242,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1721698200000},"adr":0,"listingDate":1636041600000,"adjPreClose":12.36,"openAndCloseTimeList":[[1721611800000,1721620800000],[1721624400000,1721635200000]],"volumeRatio":1.828996,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02251","defaultTab":"news","newsList":[{"id":"2452440081","title":"鹰瞳科技-B盘中异动 早盘急速跳水5.30%报12.161港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452440081","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452440081?lang=zh_cn&edition=full","pubTime":"2024-07-18 10:28","pubTimestamp":1721269733,"startTime":"0","endTime":"0","summary":"2024年07月18日早盘10时28分,鹰瞳科技-B股票出现异动,股价急速下跌5.30%。截至发稿,该股报12.161港元/股,成交量2.03万股,换手率0.04%,振幅5.14%。资金方面,该股资金流入14.109万港元,流出11.5384万港元。鹰瞳科技-B股票所在的医疗设备及用品行业中,整体涨幅为0.01%。鹰瞳科技-B公司简介:北京鹰瞳科技发展股份有限公司是一家中国公司。该公司的主营业务是提供基于人工智能的视网膜早期检测、诊断和健康风险评估解决方案。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718102853aefa3d0c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718102853aefa3d0c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02251","BK1189"],"gpt_icon":0},{"id":"2450323305","title":"鹰瞳科技:万语大模型通过国家深度合成服务算法备案 打造智能健康助手助力行业发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2450323305","media":"中国财富通","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450323305?lang=zh_cn&edition=full","pubTime":"2024-07-12 10:49","pubTimestamp":1720752543,"startTime":"0","endTime":"0","summary":"近日,国家互联网信息办公室发布第六批深度合成服务算法备案信息公告,鹰瞳科技万语大模型算法顺利通过该备案。据悉,目前已经应用于天津鹰瞳综合门诊部“健康助手”部分。据介绍,鹰瞳万语医疗大模型在五个关键方面具有独特优势,使其在医疗领域中展现出卓越的性能和潜力。目前,鹰瞳科技产品广泛应用于医院、社区诊所、体检中心、保险公司、视光中心及药房等场所,为用户提供疾病辅助诊断及健康风险评估。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://irb.cfbond.com/api/v1/detail.html?newsid=lJUupvbVxrU%3D","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1189","02251"],"gpt_icon":0},{"id":"2448181822","title":"一脉阳光医学影像产业项目持续推进 成众多耐心资本标的","url":"https://stock-news.laohu8.com/highlight/detail?id=2448181822","media":"中金在线","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448181822?lang=zh_cn&edition=full","pubTime":"2024-07-02 15:45","pubTimestamp":1719906324,"startTime":"0","endTime":"0","summary":"医学影像服务第一股一脉阳光上市以来成为市场关注热点,6月28日,作为港股通半年度核查前的最后一个交易日。分析指出,一脉阳光作为港股稀缺标的,有望成为更多耐心资本关注的标的,下一轮港股通窗口期已经于7月2日开启。另一方面,一脉阳光在医学影像产业项目及布局持续推进。从官方消息可查,一脉阳光正在进一步扩充医学影像中心网络,不断有新项目落地。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407021552319565015c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407021552319565015c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02251","BK1219","BK1189","02522"],"gpt_icon":0},{"id":"2448971892","title":"港股异动 | 一脉阳光(02522)跌超8% 股价暂现五连阴 公司为国内医学影像领域的领军企业","url":"https://stock-news.laohu8.com/highlight/detail?id=2448971892","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448971892?lang=zh_cn&edition=full","pubTime":"2024-07-02 09:49","pubTimestamp":1719884998,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,一脉阳光(02522)跌超8%,股价暂现五连阴。截至发稿,跌8.13%,报16.5港元,成交额143.43万港元。据悉,一脉阳光为国内医学影像领域的领军企业,运营着共计97家影像中心,遍布全国各地。招股书显示,2021年、2022年和2023年,一脉阳光营收分别为5.92亿元、7.84亿元及9.29亿元,复合年增长率为25.3%。此外,公司的盈利能力也在逐年提升,2023年实现扭亏为盈,净利润为3657.4万元。高盛此前指,看好一脉阳光线下影像中心和线上影像云服务平台相结合的业务模式以及公司具有丰富医学影像设备销售、运营管理经验的团队,并持续看好中国第三方影像中心行业。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1144102.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1189","YANG","02522","07226","HSTECH","HSCEI","BK1219","02251"],"gpt_icon":0},{"id":"2448971326","title":"鹰瞳科技-B盘中异动 大幅下挫5.59%报13.501港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448971326","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448971326?lang=zh_cn&edition=full","pubTime":"2024-07-02 09:48","pubTimestamp":1719884931,"startTime":"0","endTime":"0","summary":"2024年07月02日早盘09时48分,鹰瞳科技-B股票出现异动,股价急速下跌5.59%。截至发稿,该股报13.501港元/股,成交量0股,换手率0.00%,振幅0.00%。鹰瞳科技-B股票所在的医疗设备及用品行业中,整体涨幅为0.05%。其相关个股中,高视医疗、微创医疗、沛嘉医疗-B涨幅较大,振幅较大的相关个股有沛嘉医疗-B、微泰医疗-B、业聚医疗,振幅分别为5.70%、4.97%、4.72%。鹰瞳科技-B公司简介:北京鹰瞳科技发展股份有限公司是一家中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240702094851aef77ac2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240702094851aef77ac2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1189","02251"],"gpt_icon":0},{"id":"2446502863","title":"大股东Mialkos Tomasz Jakub增持鹰瞳科技-B(02251)23.5万股 每股作价约15港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446502863","media":"智通财经网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446502863?lang=zh_cn&edition=full","pubTime":"2024-06-28 20:23","pubTimestamp":1719577423,"startTime":"0","endTime":"0","summary":"6月26日,Mialkos Tomasz Jakub增持鹰瞳科技-B(02251)23.5万股,平均每股作价为15.0005港元,总金额约为352.62万港元。","market":"sg","thumbnail":"https://img.zhitongcaijing.com/image/20240628/20240628202421_82748.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20240628/20240628202421_82748.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1142860.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["02251","BK1189"],"gpt_icon":0},{"id":"2446178875","title":"鹰瞳科技-B(02251)股价显著上升10.41%,现价港币$14.0","url":"https://stock-news.laohu8.com/highlight/detail?id=2446178875","media":"阿斯达克财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446178875?lang=zh_cn&edition=full","pubTime":"2024-06-28 10:05","pubTimestamp":1719540300,"startTime":"0","endTime":"0","summary":"[上升股]鹰瞳科技-B(02251) 股价在上午10:05比前收市价显著上升10.41%,现股价为港币$14.0。至目前为止,今日最高价为$14.0,而最低价为$12.38。总成交量为6.11万股,总成交金额为港币$79.59万。","market":"us","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180112133337750_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180112133337750_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR240628422/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02251","BK1189"],"gpt_icon":0},{"id":"2446512964","title":"港股异动 | 一脉阳光(02522)早盘急挫逾20%跌破发行价 公司为国内医学影像领域的领军企业","url":"https://stock-news.laohu8.com/highlight/detail?id=2446512964","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446512964?lang=zh_cn&edition=full","pubTime":"2024-06-28 09:55","pubTimestamp":1719539748,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,一脉阳光(02522)早盘急跌近20%,低见14.5港元,再度跌破发行价14.98港元。截至发稿,跌18.18%,报15.12港元,成交额363.19万港元。据悉,一脉阳光为国内医学影像领域的领军企业,运营着共计97家影像中心,遍布全国各地。招股书显示,2021年、2022年和2023年,一脉阳光营收分别为5.92亿元、7.84亿元及9.29亿元,复合年增长率为25.3%。高盛此前指出,看好一脉阳光线下影像中心和线上影像云服务平台相结合的业务模式以及公司具有丰富医学影像设备销售、运营管理经验的团队,并持续看好中国第三方影像中心行业。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1142197.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02251","YANG","HSTECH","HSCEI","BK1189","07226","02522","BK1219"],"gpt_icon":0},{"id":"2446947514","title":"鹰瞳科技-B盘中异动 早盘股价大涨6.77%报13.540港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446947514","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446947514?lang=zh_cn&edition=full","pubTime":"2024-06-28 09:46","pubTimestamp":1719539202,"startTime":"0","endTime":"0","summary":"2024年06月28日早盘09时46分,鹰瞳科技-B股票出现异动,股价快速拉升6.77%。截至发稿,该股报13.540港元/股,成交量4.22万股,换手率0.08%,振幅5.68%。资金方面,该股资金流入37.121万港元,流出12.5712万港元。鹰瞳科技-B股票所在的医疗设备及用品行业中,整体涨幅为0.04%。其相关个股中,紫元元、鹰瞳科技-B、昊海生物科技涨幅较大,振幅较大的相关个股有鹰瞳科技-B、沛嘉医疗-B、紫元元,振幅分别为5.68%、5.00%、4.76%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240628094642aef701c1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240628094642aef701c1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1189","02251"],"gpt_icon":0},{"id":"2446451698","title":"港股概念追踪 |为医生节省大量的时间 中金看好AI对医疗行业生产率提升将较大(附概念股)","url":"https://stock-news.laohu8.com/highlight/detail?id=2446451698","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446451698?lang=zh_cn&edition=full","pubTime":"2024-06-28 09:09","pubTimestamp":1719536948,"startTime":"0","endTime":"0","summary":"对于医生群体来说,最热门的新技术——AI,有望带回一种古老的医疗实践方式:与病人们进行面对面交谈。DAX Copilot总经理Kenneth Harper表示,现在有高达200多个组织在使用这项技术。未来十年,AI对采矿、医疗、资源加工、信息、租赁和商务服务等行业的生产率提升较大,对批发零售、住宿餐饮、轻工制造等行业的生产率提升较小。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1142167.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1518","HSTECH","BK1189","159891","02251","HSCEI","07226","YANG","02158"],"gpt_icon":0},{"id":"2446305625","title":"鹰瞳科技-B(02251)下跌13.73%,报12.94元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2446305625","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446305625?lang=zh_cn&edition=full","pubTime":"2024-06-27 14:27","pubTimestamp":1719469657,"startTime":"0","endTime":"0","summary":"6月27日,鹰瞳科技-B(02251)盘中下跌13.73%,截至14:27,报12.94元/股,成交100.84万元。北京鹰瞳科技发展股份有限公司主要业务是为慢性病的早期检测、辅助诊断及健康风险评估提供全面和多方位的人工智能解决方案,特别是在全球视网膜影像人工智能领域处于领先地位。公司的糖尿病视网膜病变辅助诊断软件是首个获得国家药监局第三类医疗器械证书的同类产品,已广泛应用于社区诊所、体检中心、保险公司、视光中心及药房等场所,为用户提供疾病辅助诊断及健康风险评估。截至2023年年报,鹰瞳科技-B营业总收入2.04亿元、净利润-1.33亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/06/27142741231765.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1189","02251"],"gpt_icon":0},{"id":"2446377971","title":"鹰瞳科技-B(02251)股价下跌8.533%,现价港币$13.72","url":"https://stock-news.laohu8.com/highlight/detail?id=2446377971","media":"阿斯达克财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446377971?lang=zh_cn&edition=full","pubTime":"2024-06-27 13:05","pubTimestamp":1719464700,"startTime":"0","endTime":"0","summary":"[下跌股]鹰瞳科技-B(02251) 股价在下午01:05比前收市价下跌8.533%,现股价为港币$13.72。至目前为止,今日最高价为$15.08,而最低价为$13.72。总成交量为3.538万股,总成交金额为港币$50.902万。","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180205152742524_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180205152742524_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2406272900/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02251","BK1189"],"gpt_icon":0},{"id":"2446737143","title":"鹰瞳科技-B盘中异动 大幅下挫5.34%报14.200港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446737143","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446737143?lang=zh_cn&edition=full","pubTime":"2024-06-27 10:54","pubTimestamp":1719456885,"startTime":"0","endTime":"0","summary":"2024年06月27日早盘10时54分,鹰瞳科技-B股票出现波动,股价快速下挫5.34%。截至发稿,该股报14.200港元/股,成交量1.35万股,换手率0.03%,振幅5.87%。资金方面,该股资金流入14.8728万港元,流出5.3102万港元。鹰瞳科技-B股票所在的医疗设备及用品行业中,整体跌幅为0.17%。其相关个股中,佳兆业健康、加和国际控股、心泰医疗涨幅较大,振幅较大的相关个股有紫元元、微创机器人-B、心泰医疗,振幅分别为12.78%、12.57%、10.80%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240627105445941f1a6e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240627105445941f1a6e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1189","02251"],"gpt_icon":0},{"id":"2443740495","title":"广宇集团:投资者朋友,公司持有杭州全景医学影像诊断有限公司20%的股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2443740495","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443740495?lang=zh_cn&edition=full","pubTime":"2024-06-13 17:03","pubTimestamp":1718269403,"startTime":"0","endTime":"0","summary":"证券之星消息,广宇集团(002133)06月13日在投资者关系平台上答复投资者关心的问题。投资者:你好 一脉阳光已ipo 请问经营排行巨首位公司参股全景医学是否已经在上市进展中 谢谢广宇集团董秘:投资者朋友,你好。公司持有杭州全景医学影像诊断有限公司20%的股权。该参股公司未来的发展计划敬请以公司公告信息为准。谢谢关注。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024061300032630.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0273","002133","BK1189","02251"],"gpt_icon":0},{"id":"2441506210","title":"稀缺标的港股上市,医学影像第一股迈入高增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2441506210","media":"36氪","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441506210?lang=zh_cn&edition=full","pubTime":"2024-06-07 18:57","pubTimestamp":1717757842,"startTime":"0","endTime":"0","summary":"6月7日,江西一脉阳光股份有限公司(股票代码: 2522HK; 以下简称: 一脉阳光)在港交所挂牌上市,成为了第一家在港上市的第三方医学影像企业。 于完整的簿记期后公告了全球发售结果: 国配超1.3倍,香港公开发售超336倍,市场认购火爆。 一脉阳光成立于2014年,彼时由多名行业精英共同投资创建,经过多年的发展,目前形...","market":"hk","thumbnail":"https://inews.gtimg.com/om_ls/OVXE5AhyGlrNYf2c11KgKyqpiiKlKGQpZ4g263LbqmwqkAA_294195/0","type":0,"news_type":0,"thumbnails":["https://inews.gtimg.com/om_ls/OVXE5AhyGlrNYf2c11KgKyqpiiKlKGQpZ4g263LbqmwqkAA_294195/0"],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20240607A09CJU00","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20240607A09CJU00","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent_tech","symbols":["02251","07226","HSTECH","BK1189","YANG","HSCEI"],"gpt_icon":0},{"id":"2441055336","title":"医学影像专科医疗集团一脉阳光今日在港交所上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2441055336","media":"腾讯自选股","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441055336?lang=zh_cn&edition=full","pubTime":"2024-06-07 18:02","pubTimestamp":1717754520,"startTime":"0","endTime":"0","summary":"上证报中国证券网讯 江西一脉阳光集团股份有限公司 6月7日在港交所上市。一脉阳光此次发行价14.98港元,发行1781.6万股。公开资料显示,一脉阳光是一家医学影像专科医疗集团,主要从事医学影像中心投资运营,医学影像云平台技术开发、医学影像人才培养、医学影像产业链服务。截至2023年12月31日,公司在中国设立及管理97个影像中心。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/hk/2024-06-07/doc-inaxxcsc7100511.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/hk/2024-06-07/doc-inaxxcsc7100511.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1189","159891","02251","02522"],"gpt_icon":0},{"id":"2441125087","title":"新股解读|一脉阳光:上市锻造龙头增长势能 打造中国医学影像服务产业名片","url":"https://stock-news.laohu8.com/highlight/detail?id=2441125087","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441125087?lang=zh_cn&edition=full","pubTime":"2024-06-07 14:48","pubTimestamp":1717742883,"startTime":"0","endTime":"0","summary":"龙头布局价值逐步抬升,港股资本市场将迎来又一龙头企业,中国医学影像服务赛道的龙头一脉阳光。根据弗若斯特沙利文的资料,一脉阳光是中国唯一一家为整个医学影像产业链提供多元化影像服务及价值的医学影像平台运营商及管理者。人员方面,一脉阳光拥有的超过230个执业影像医生也是业内最多。一脉阳光同期持有32张有效的第三方医学影像中心许可证,按许可证数目计,在中国所有第三方医学影像中心运营商中排名第一。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1132619.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02522","BK1189","02251"],"gpt_icon":0},{"id":"2441082479","title":"新股消息 | 一脉阳光(02522)今日港交所上市 为中国医学影像服务第一股","url":"https://stock-news.laohu8.com/highlight/detail?id=2441082479","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441082479?lang=zh_cn&edition=full","pubTime":"2024-06-07 14:31","pubTimestamp":1717741890,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,6月7日,一脉阳光正式在港交所主板挂牌上市,成为“中国医学影像服务第一股”。从招股情况来看,一脉阳光本次IPO中发行17,816,000股股份。高盛表示,看好一脉阳光线下影像中心和线上影像云服务平台相结合的业务模式以及公司具有丰富医学影像设备销售、运营管理经验的团队,并持续看好中国第三方影像中心行业,认为将是中国医疗服务领域最具发展前景的市场之一。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1132606.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1189","02522","02251"],"gpt_icon":0},{"id":"2441970074","title":"“医学影像服务第一股”诞生,一脉阳光登陆港交所开盘涨超9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2441970074","media":"地产k线","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441970074?lang=zh_cn&edition=full","pubTime":"2024-06-07 11:27","pubTimestamp":1717730849,"startTime":"0","endTime":"0","summary":"瑞财经 王敏6月7日,一脉阳光登陆港交所,截至9:32,一脉阳光涨9.48%,报16.40港元,成交额1.19亿港元,总市值58.44亿港元。据悉,一脉阳光于2023年5月11日首次递交港交所上市申请,后于2023年11月13日和2024年5月13日两次更新招股书。由于此前尚无这类以第三方医学影像服务为主的公司上市,一脉阳光因此成为了“医学影像服务第一股”。股权方面,截至最后实际可行日期,南昌一脉直接持有一脉阳光约17.4562%的股本。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406071153439596fd89&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406071153439596fd89&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02251","BK1189","02522"],"gpt_icon":0},{"id":"2441176732","title":"鹰瞳科技-B06月06日获主力加仓114万元 环比增加533.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2441176732","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441176732?lang=zh_cn&edition=full","pubTime":"2024-06-06 16:16","pubTimestamp":1717661798,"startTime":"0","endTime":"0","summary":"06月06日, 鹰瞳科技-B股价跌0.27%,报收14.84元,成交金额466万元,换手率0.59%,振幅2.69%,量比1.76。鹰瞳科技-B今日主力资金净流入114万元,连续3日净流入,上一交易日主力净流入18万元,今日环比增加533.33%。该股近5个交易日下跌1.46%,主力资金累计净流入175万元;近20日主力资金累计净流入277万元,其中净流入天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024060616172795940df9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024060616172795940df9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02251","BK1189"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.1058},{"period":"1month","weight":-0.1979},{"period":"3month","weight":-0.1925},{"period":"6month","weight":0.0435},{"period":"1year","weight":0.1472},{"period":"ytd","weight":-0.0083}],"compareEarnings":[{"period":"1week","weight":-0.0211},{"period":"1month","weight":-0.0218},{"period":"3month","weight":0.048},{"period":"6month","weight":0.1092},{"period":"1year","weight":-0.0755},{"period":"ytd","weight":0.0345}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"鹰瞳Airdoc成立于2015年9月,总部在北京,截至2020年1月底,公司在北京、上海、广州、香港设立了子公司及研发中心。\n鹰瞳Airdoc是全球视网膜影像人工智能领域的领导者和先行者,公司基于视网膜影像人工智能识别的早期检测、辅助诊断及健康风险评估解决方案,通过视网膜影像、多模态数据分析以及人工智能深度学习算法,改善了慢性病传统的早期检测及诊断方式,在医疗机构和大健康场景中实现对慢性病的无创、精确、快速、高性价比且大规模的诊断及相关健康风险评估。\n2020年8月,鹰瞳Airdoc糖尿病视网膜病变眼底图像辅助诊断软件获国家药监局批准上市,在同类产品中首个获得国家药监局第三类医疗器械证书,并由此展开在国内医院的使用,协助及减轻医生的医学诊断工作。为解决未满足的医疗健康需求,公司开发了人工智能视网膜影像相关的丰富产品管线,已广泛应用于社区诊所、体检中心、保险公司、验光中心及药房等场所,为用户提供疾病辅助诊断及健康风险评估","exchange":"SEHK","name":"鹰瞳科技-B","nameEN":"AIRDOC-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"鹰瞳科技-B(02251)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供鹰瞳科技-B(02251)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"鹰瞳科技-B,02251,鹰瞳科技-B股票,鹰瞳科技-B股票老虎,鹰瞳科技-B股票老虎国际,鹰瞳科技-B行情,鹰瞳科技-B股票行情,鹰瞳科技-B股价,鹰瞳科技-B股市,鹰瞳科技-B股票价格,鹰瞳科技-B股票交易,鹰瞳科技-B股票购买,鹰瞳科技-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"鹰瞳科技-B(02251)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供鹰瞳科技-B(02251)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}